Comparing Elinzanetant with Current Options for VMS and Sleep Management

This episode notes that elinzanetant offers a targeted, non-hormonal option for women seeking relief from both vasomotor symptoms and sleep disturbances, which is an important consideration for those who cannot or prefer not to use hormone therapy. Other treatments, such as cognitive behavioral therapy for insomnia, may still play a valuable role for certain patients, reinforcing that menopause care often requires a personalized approach. The segment underscores that having multiple evidence-based options expands flexibility and improves individualized care.